Coordination of Care/Care Transitions


The tumor board, or multidisciplinary cancer conference (MCC), is the foundation of high-value multidisciplinary oncology care through coordinating teams of specialists.


Accessing chimeric antigen receptor (CAR) T-cell clinical trials for relapsed and refractory B-cell acute lymphoblastic leukemia (ALL) is challenging for pediatric patients who have experienced a relapse of B-cell ALL or have been refractory to standard therapy.


In preparation for the upcoming certification test, information is provided on the essential function of nurse navigations in care coordination to assist navigators.


A review of the literature was done to evaluate the current evidence regarding the barriers that influence the transition of care in cancer survivorship and impact patient quality of life (QOL) and health outcomes.

Page 7 of 7

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country